Navigation Links
HTH Worldwide Unveils First Digital Healthcare Card
Date:10/27/2008

My Digital ID for Travelers Makes Doctor Visits Abroad Even Easier

RADNOR, Pa., Oct. 27 /PRNewswire/ -- HTH Worldwide, a global health and safety services company, today announced the introduction of My Digital ID, the world's first digital healthcare card. My Digital ID enables HTH members to access all the information on their health plan identification card via their mobile phone. Global travelers can rely on direct access to HTH's eligibility database to show proof of coverage and to initiate international assistance services with one click.

"HTH health plan members who carry mobile phones with internet access need not worry about losing or misplacing their healthcare card," said Angelo Masciantonio, Chief Executive Officer of HTH Worldwide. "HTH has put its market-leading mobile technology to create an industry first. We are working to make it more convenient than ever for our members to carry the information they need to get care from top medical providers all around the world. My Digital ID is an important addition to our mPassport(SM) suite of mobile tools and databases our members use to find carefully selected doctors and hospitals in 180 countries."

HTH is rolling out this service initially to members of its international student and study abroad plans. All the elements of HTH's standard healthcare cards -- including school and provider network logos -- are formatted to comfortably fit the mobile phone screen. The service will be expanded to HTH's health plans for business and leisure travelers and expatriates by the end of the year.

HTH Worldwide has a long history as a leading innovator in web and mobile applications designed to create prompt access to quality healthcare services. The company's achievements include

-- An online process for broadcasting and monitoring requests for doctor appointments patented in the U.S. and Australia;

-- A database of profiles of over 5,000 carefully selected doctors and
'/>"/>

SOURCE HTH Worldwide
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
2. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
3. Global Med Technologies(R) Extends Its Worldwide Outreach
4. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
5. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
6. New USAID grant helps Georgetown meet unmet family planning needs worldwide
7. The Cardiovascular Multimedia Network (CVMD) and the International Society of Endovascular Specialists (ISES) Join Forces to Educate Practitioners Worldwide Through Electronic Media
8. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
9. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
10. Allscripts Featured in Microsoft HealthVault Worldwide Launch
11. Abortion Numbers Fall Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... 2015 , ... Ogawa’s new massage chairs tout innovative functionality that change the ... ever before. With the goal of bringing wellness to the world, Ogawa introduces their ... , As in its name, the Ogawa Refresh aims to “refresh” and ...
(Date:9/1/2015)... ... September 01, 2015 , ... USA Medical Card, a leading ... to coincide with back-to-school and the start of “sick season” for many households ... school children are sick an average of 8 to 12 times each school ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... VitaSkin™ collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of natural ... Firm, Bright, Calm, and Clear. , Formulated with alpha hydroxy acids and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Dr. Trace Curry successfully placed one of the ... the last month the FDA has approved two intra-gastric balloons, the ORBERA ™ ... the first incisionless, reversible, weight loss procedures available to Americans. , Dr. ...
(Date:9/1/2015)... (PRWEB) , ... September 01, ... ... announce PRO Archiver for Alfresco, a next-generation customer communications archiving solution integrated ... with market-leading technology from Crawford and helps organizations save millions of dollars ...
Breaking Medicine News(10 mins):Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3
... TITAN Technology Partners, a,global provider of hosted and ... company in North Carolina in 2006, announced,today Valley ... signed a multi-year agreement to leverage TITAN,s Hosting ... Capital Management,applications throughout the organization for over 2,500 ...
... Feb. 29 Landauer, Inc. (NYSE:,LDR) announced today that ... of $0.50 per share for the second quarter of ... 2008, to shareholders of record,on March 14, 2008., ... analytical services to determine,occupational and environmental radiation exposure. For ...
... supplements do not protect against lung cancer, according to ... fact, some supplements may even increase the risk of ... C, vitamin E and folate did not show any ... the studys author, Christopher G. Slatore, M.D., of the ...
... to treat an aggressive form of breast cancer are ... in 50 countries across six continents -- a clinical ... for global cancer research. This trial, dubbed ALTTO (Adjuvant ... of the first global initiatives in which two large, ...
... into allergic reactions, deaths related to blood thinner continues ... Corp., the pharmaceutical company at the center of recent ... it was recalling any remaining multi-dose vials of the ... also said it was recalling its Hep-Lock heparin flush ...
... In a tradition dating,back to Franklin Delano Roosevelt, ... calling it a time to "honor this charitable,organization" and ... In a Proclamation signed today, the President cited ... and medical assistance to the victims,of a number of ...
Cached Medicine News:Health News:Valley Baptist Health System Leveraging TITAN Technology Partners Hosting and Managed Services 2Health News:Certain vitamin supplements may increase lung cancer risk, especially in smokers 2Health News:New study of targeted therapies for breast cancer -- model for global clinical trials 2Health News:New study of targeted therapies for breast cancer -- model for global clinical trials 3Health News:New study of targeted therapies for breast cancer -- model for global clinical trials 4Health News:Baxter Recalls Rest of Heparin Products 2Health News:Baxter Recalls Rest of Heparin Products 3Health News:President Bush Declares March as Red Cross Month 2Health News:President Bush Declares March as Red Cross Month 3
(Date:8/31/2015)...  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... subsidiary, Dougherty,s Holdings, has acquired Springtown Drug (" ... Springtown, Texas , just north of ... pharmacy has provided retail prescriptions, healthcare products and gifts ... . The Springtown ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015 The ... reversed statewide since Pennsylvania State ... life-saving drug kits, naloxone. Heroin and opioid ... Pennsylvania , killing more individuals than ... approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... June 9 Halozyme Therapeutics,Inc. (Nasdaq: ... products targeting the extracellular matrix, today,announced new ... mellitus program at,the American Diabetes Association,s 68th ... company,s proprietary recombinant human,hyaluronidase enzyme (rHuPH20) with ...
... Pivotal Study Highlighted at Recent Arizona Alzheimer,s ... Consortium Annual Conference in Phoenix -, PHOENIX and ... Health Research Institute today announced that they are,actively enrolling patients ... treatment of Alzheimer,s disease. The study will,evaluate the safety and ...
Cached Medicine Technology:Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3